Literature DB >> 28510067

Immunization During Pregnancy: Impact on the Infant.

Kirsten P Perrett1,2,3, Terry M Nolan4.   

Abstract

Maternal immunization has undergone a paradigm shift in recent years, as women and healthcare providers accept and recognize the benefits of this strategy not only for the pregnant woman but also for the developing fetus and young infant. This article reviews the evidence for active immunization during pregnancy, with an emphasis on perinatal and infant outcomes. Current recommendations for immunization during pregnancy are presented, with particular focus on the routinely recommended vaccines during pregnancy: influenza and Tdap (tetanus, diphtheria, and pertussis). We discuss future research directions, maternal vaccines in development, and considerations for optimizing and advancing this underutilized strategy.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28510067     DOI： 10.1007/s40272-017-0231-7

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN： 1174-5878            Impact factor:   3.022


  109 in total

1.  A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women.

Authors:  Geert Leroux-Roels; Cathy Maes; Julie Willekens; Fien De Boever; Richard de Rooij; Leah Martell; Lisa Bedell; Frederick Wittke; Karen Slobod; Peter Dull
Journal:  Vaccine       Date:  2016-03-05       Impact factor: 3.641

2.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

Authors:  H W Kim; J G Canchola; C D Brandt; G Pyles; R M Chanock; K Jensen; R H Parrott
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

3.  Use of tetanus toxoid for the prevention of neonatal tetanus. 1. Reduction of neonatal mortality by immunization of non-pregnant and pregnant women in rural Bangladesh.

Authors:  M Rahman; L C Chen; J Chakraborty; M Yunus; A I Chowdhury; A M Sarder; S Bhatia; G T Curlin
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

4.  Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age.

Authors:  Nicholas Wood; Peter McIntyre; Helen Marshall; Don Roberton
Journal:  Pediatr Infect Dis J       Date:  2010-03       Impact factor: 2.129

5.  Effectiveness of maternal pertussis vaccination in England: an observational study.

Authors:  Gayatri Amirthalingam; Nick Andrews; Helen Campbell; Sonia Ribeiro; Edna Kara; Katherine Donegan; Norman K Fry; Elizabeth Miller; Mary Ramsay
Journal:  Lancet       Date:  2014-07-15       Impact factor: 79.321

6.  H1N1 2009 influenza virus infection during pregnancy in the USA.

Authors:  Denise J Jamieson; Margaret A Honein; Sonja A Rasmussen; Jennifer L Williams; David L Swerdlow; Matthew S Biggerstaff; Stephen Lindstrom; Janice K Louie; Cara M Christ; Susan R Bohm; Vincent P Fonseca; Kathleen A Ritger; Daniel J Kuhles; Paula Eggers; Hollianne Bruce; Heidi A Davidson; Emily Lutterloh; Meghan L Harris; Colleen Burke; Noelle Cocoros; Lyn Finelli; Kitty F MacFarlane; Bo Shu; Sonja J Olsen
Journal:  Lancet       Date:  2009-07-28       Impact factor: 79.321

7.  Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013.

Authors:  Elyse Olshen Kharbanda; Gabriela Vazquez-Benitez; Heather S Lipkind; Nicola P Klein; T Craig Cheetham; Allison L Naleway; Grace M Lee; Simon Hambidge; Michael L Jackson; Saad B Omer; Natalie McCarthy; James D Nordin
Journal:  Vaccine       Date:  2016-01-04       Impact factor: 3.641

8.  Parental Tdap boosters and infant pertussis: a case-control study.

Authors:  Helen E Quinn; Thomas L Snelling; Andrew Habig; Clayton Chiu; Paula J Spokes; Peter B McIntyre
Journal:  Pediatrics       Date:  2014-09-15       Impact factor: 7.124

9.  Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women.

Authors:  Christine E Jones; Flor M Munoz; Hans M L Spiegel; Ulrich Heininger; Patrick L F Zuber; Kathryn M Edwards; Philipp Lambach; Pieter Neels; Katrin S Kohl; Jane Gidudu; Steven Hirschfeld; James M Oleske; Najwa Khuri-Bulos; Jorgen Bauwens; Linda O Eckert; Sonali Kochhar; Jan Bonhoeffer; Paul T Heath
Journal:  Vaccine       Date:  2016-07-29       Impact factor: 3.641

10.  Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-02-22       Impact factor: 17.586
View more
  3 in total

1.  Adverse events following immunization in pregnant women from Minas Gerais.

Authors:  Isabela Oliveira da Silveira; Thales Philipe Rodrigues da Silva; Bianca Maria Oliveira Luvisaro; Roberta Barros da Silva; Josianne Dias Gusmão; Aline Mendes Vimieiro; Valéria Conceição de Oliveira; Karina Cristina Rouwe de Souza; Ana Paula Vieira Faria; Fernanda Penido Matozinhos
Journal:  Rev Saude Publica       Date:  2021-05-17       Impact factor: 2.772

Review 2.  Maternal Vaccination as an Essential Component of Life-Course Immunization and Its Contribution to Preventive Neonatology.

Authors:  Naomi Bergin; Janice Murtagh; Roy K Philip
Journal:  Int J Environ Res Public Health       Date:  2018-04-25       Impact factor: 3.390

3.  Seroprevalence Study of Pertussis in Adults at Childbearing Age and Young Infants Reveals the Necessity of Booster Immunizations in Adults in China.

Authors:  Zhiyun Chen; Jie Pang; Nan Zhang; Ning Chen; Yiwei Ding; Qiushui He
Journal:  Vaccines (Basel)       Date:  2022-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.